Pharmacy Laws, Immunization Changes, Standard Care Transition

C ALIFORNIA ST A TE BO ARD OF PHARM A C Y THE SCRIPT

November 2025

BE AWARE & TAKE CARE: Talk to your pharmacist! Contents

President's Message.............................. 2

Upcoming Meetings............................. 5

Regulations.............................................. 6

Immunization Alert AB 1503 ............ 7

Are You Administering the Correct

Vaccine? ................................................... 8

CAMER

Reporting Medication Errors...........10

From the CAMER Database:.............11

Inspection Results Enforcement and Compounding New Laws Committee Releases Report on

Inspections.............................................12

2024-2025 Fiscal Year .........................14 Governor Gavin Newsom has enacted several bills that

introduce or revise existing laws regulating pharmacy practice Pharmacist in Charge Training in California. To read the full text of each law, click on the Webinar...................................................15

Assembly bill (AB) number or Senate bill (SB) number. Striking the Right Balance Technology and the Pharmacist's AB 82 Health care: legally protected health care activity Role in Medication Safety.................16 (Ward, Chapter 679, Statutes of 2025)

AB 82 expands condentiality for reproductive and gender-Albuterol and Epinephrine arming health care providers. The bill protects addresses Standing Orders for Schools............ 17

of health care providers, employees, or volunteers who face Report a Drug Theft/Drug Loss threats of violence or harassment from the public. This bill also Online Portal .........................................17 prohibits a prescription for or the dispensing of testosterone

Board Welcomes New Members ....18 or mifepristone from being reported to the Department of

Justice, CURES, or a contractor. Board Honors 40-Year

Pharmacists ..........................................18 AB 144 Committee on Budget. Health

Well-Being Index (Chapter 105, Statutes of 2025)

Mental Health Support...................... 19 AB 144 establishes California's baseline for vaccine coverage

for the immunization schedule recommended by the Advisory Check and See: Is it an Authorized Committee on Immunization Practices as of January 1, 2025. Dealer? ....................................................19

It authorizes the California Disciplinary Actions............................20

See New Laws, Page 3

PRESIDENT'S MESSAGE

to vaccine administration for reproductive and gender- arming health care providers enacted by AB 1503. Under (AB 82 and AB 260), lowering the provisions established in the cost of prescription drugs AB 1503,pharmacist authority (SB 41), and cutting down on to independently initiate and medication waste for emergency administer vaccines for persons room patients (AB 447). three years of age and older will transition to a standard of Signing AB 1503 means the care practice model. Such an Board's operation has been approach is consistent with other extended for four more years health care practitioners with until January 1, 2030. With similar practice authority. AB 1503 the Board secured changes to streamline and In anticipation of this change, transition to a more robust the Board strongly encourages By Seung Oh, President, standard of care practice pharmacists to begin the model for pharmacist and transition to a standard The year 2025 will be establish authority for pharmacy of care practice model for remembered as the very technicians to compound and immunizations for patients three signicant year for the administer vaccines outside of years old and older. The Board remarkable changes in Pharmacy a pharmacy while under the also reminds pharmacists that Law that will ultimately reduce direct supervision and control Business and Professions Code healthcare costs, improve patient of a pharmacist. The bill also section 4052(a)(11) currently well-being and health outcomes contains a provision where a provides a pharmacist with in the long run. Assembly Bill Pharmacist-in-Charge (PIC) must the authority to administer (AB) 1503, the Board's Sunset determine adequate stang immunizations to any person, Oversight Review Report, would level at the pharmacy to ensure regardless of age, pursuant to a transition pharmacists' care to a sucient personnel are present protocol with a prescriber. This standard of care practice model in the pharmacy to prevent current authority will exist until under specied conditions to fatigue, distraction, or other January 1, 2026, when AB 1503 transform the care patients may takes eect, but the authority to conditions, while allowing the receive. Ultimately, the Board establish protocol still remains PIC to determine the pharmacist believes this approach will and is renumbered under BPC to pharmacy technician ratio signicantly benet consumers. 4052(a)(12)(B). We understand of up to 1:3. The standard of Many details and more these changes can be confusing care practice model has been information will be forthcoming and will be providing further something the Board has been in the coming months and some working on for a few years and information in the coming information are included in this I am grateful to see it come to months. edition of The Script. The Board fruition. In July 2022, a Standard There is a lot of changes in will issue a special edition of of Care Ad Hoc Committee was pharmacy law and information The Script focusing on AB 1503 established. Within two years in AB 1503, and to familiarize and many other changes in the the Board had a draft proposal. licensees on the changes, the Board's Sunset bill in early 2026. The Board, via its 2025 Sunset -Board will be releasing a Special Measure, proposed a transition Other new laws were also Edition newsletter in early 2026. to standard of care practice recently signed by Governor In the meantime, I encourage model. Gavin Newsom including licensees to read this edition of fourteen new bills focused on I would like to bring to The Script. This edition includes pharmacy laws. These bills vary your attention one of the new laws and regulations, from condentiality protection upcoming changes related

See President's Message, Page 3

President's New Laws Message Continued from page 1

Department of Public Health (CDPH) to modify or supplement Continued from page 2 these baseline recommendations, considering guidance from albuterol and epinephrine leading medical organizations. It provides liability protections standing orders for schools, for people providing immunizations in accordance with CDPH the importance of vaccine recommendations through January 1, 2030. consent forms, and an article AB 260 Sexual and Reproductive Health Care why technology can't replace (Aguiar- Curry, Chapter 136, Statutes of 2025) one hundred percent of the AB 260 protects reproductive healthcare access, including pharmacist's role in patient care. medication abortion. It oers comprehensive protections for In closing, the changes secured healthcare providers, pharmacists, clinics, and hospitals from in AB 1503 will be a monumental penalties for legally prescribing or dispensing mifepristone. It change in the practice of removes the patients name, prescriber names, and name and pharmacy for the betterment address of the pharmacy from medication labels for their safety, as of patient care and access for long as the pharmacist maintains a log with specic information; decades to come. We are grateful mandates insurance coverage, including Medi-Cal, for medication to many who supported this abortion; expands access through telehealth services; prohibits a measure along the way, but health care service plan contract or a group or individual health most importantly, we are excited insurance policy or certicate that covers prescription drugs for the potential to improve from limiting or excluding coverage for brand name or generic patient care with this change. mifepristone solely on the basis that the drug is prescribed for a use The Board, as always, thanks that is dierent from the use for which the FDA has approved that all the hardworking frontline drug; and eliminates outdated and discriminatory language from employees who every day show state law such as references to "chaste character". up to take care of patients and AB 309 Hypodermic needles and syringes go out of their way to make a (Zbur, Chapter 685, Statutes of 2025) dierence in people's lives. As AB 309 deletes the January 1, 2026 repeal date that allows licensees the cold and u season is fully to provide hypodermic needles and sterile syringes for human use upon us, we like to remind all our without a prescription or permits to any person 18 years of age or licensees to stay healthy and stay older if the furnisher has previously been provided a prescription well. Finally, a friendly reminder or other proof of a legitimate medical need requiring a hypodermic in AB 1503, the Board secured needle or syringe to administer a medicine or treatment. signicant provisions in the ability for Pharmacist-in-Charge AB 447 Emergency room patient prescriptions to determine stang levels at (González, Chapter 363, Statutes of 2025) the pharmacy eective January AB 447 allows physicians or authorized prescribers to dispense an 1, 2026. The Board would like to unused portion of a non-controlled medication to an emergency ensure there is adequate support department (ED) patient upon discharge if certain conditions for you to take care of patients are met: the drug is not a controlled substance, the medication in whatever setting you are in. -was previously ordered and administered to the patient during And we are always here to listen their ED visit, and the unused portion of the drug is required to to your ideas; please come to our continue treatment of the patient. This will cut down on medication meetings in person or virtually, waste. This bill also exempts from licensure an AUDS that is used submit comments, and provide to dispense dangerous drugs to emergency room patients in feedback. Thank you for all you accordance with specied requirements. do to take care of California patients! See New Laws, Page 4

New Laws

Continued from page 3

AB 489 Health care professions: deceptive terms SB 41 establishes the regulation of Pharmacy Benet Managers (PBMs) within the California or letters: articial intelligence (Bonta, Chapter 615, Statutes of 2025) Department of Managed Healthcare (DMHC) as AB 489 prohibits the use by articial intelligence specied, including the following: (AI) or generative articial intelligence (GenAI) • Prohibits a PBM from requiring use of only technology of certain terms, letters, or phrases that an aliated pharmacy. indicate or imply that the advice, care, reports, or • Establishes actions that are prohibited by a assessments being provided through AI or GenAI is being provided by a natural person with the PBM. appropriate health care license or certicate. • Establishes disclosure obligations on PBMs. AB 1152 Controlled substances: human • Requires PBMs to use a passthrough pricing chorionic gonadotropin (Patterson, Chapter 182, Statutes of 2025) model. AB 1152 removes human chorionic gonadotropin Additional information can be obtained from the (hCG) from the list of Schedule III controlled California Department of Managed Healthcare. substances under the California Uniform Controlled Substances Act. SB 306 Health care coverage: prior authorizations AB 1503 (Becker, Chapter 408, Statutes of 2025) Sunset Oversight Review Report SB 306 requires health care service plans and (Berman, Chapter 196, Statutes of 2025) health insurers to report statistics to the DMHC and The Board submitted its Sunset Oversight Review the Department of Insurance annually beginning Report on January 6, 2025. The report included December 31, 2026, and, starting January 1, 2028, several statutory proposals. Many of the policy to cease requiring prior authorization for the most proposals are included in the Board's sunset frequently approved covered health care services measure. This bill makes changes to Pharmacy Law that are approved at a rate that meets or exceeds and Board operations, including extending the the threshold rate of 90%. These requirements will Board for four years until January 1, 2030. A Special be repealed on January 1, 2034. Edition of The Script will be released dedicated to the amendments of AB 1503. SB 470 Bagley-Keene Open Meeting Act: teleconferencing SB 40 Health care coverage: insulin (Laird, Chapter 222, Statutes of 2025) (Wiener, Chapter 737, Statutes of 2025) SB 470 authorizes a state body to hold a Senate Bill (SB) 40 would prohibit a health care meeting by teleconference subject to specied service plan or health insurer from imposing step requirements, including, among others, that at therapy as a prerequisite to authorizing coverage least one member of the state body is physically of insulin and would generally prohibit a health present at each teleconference location, as dened, care service plan contract or health insurance that a majority of the members of the state body policy issued, amended, delivered, or renewed - are physically present at the same teleconference on or after January 1, 2026, from imposing a location, except as specied, and that members copayment, coinsurance, deductible, or other cost of the state body visibly appear on camera during sharing of more than $35 for a 30-day supply of an the open portion of a meeting that is publicly insulin prescription drug, except as specied. accessible via the internet or other online platform, SB 41 Pharmacy benets  except as specied. Under specied circumstances, (Wiener, Chapter 605, Statutes of 2025)

See New Laws, Page 5

New Laws

Continued from page 4 • An out-of-state user from providing any

the act authorizes a member of the state body to participate from an undisclosed remote location data in furtherance of an investigation or that is not accessible to the public. This authority proceeding to impose liability based on will be repealed on January 1, 2030. another state's law for the provision or receipt of legally protected health care SB 497 Legally protected health care activity activity. (Wiener, Chapter 764, Statutes of 2025) SB 497 prohibits: SB 568 Pupil health: epinephrine delivery systems: school sites and childcare programs • The release of medical information related (Niello, Chapter 322, Statutes of 2025) SB 568 expands the authority of pharmacies to to a person seeking or obtaining gender- provide a broader range of epinephrine delivery arming health care or gender-arming devices, including those other than auto-injectors, mental health care in response to a to local educational agencies--including school criminal or civil action, including a foreign districts, county oces of education, and charter subpoena, based on another state's law that schools--under existing safety and training interferes with an individual's right to seek requirements. or obtain gender-arming health care or gender-arming mental health care. For questions or to learn more about these new • Cooperation with or providing medical laws, please visit contact the Ask and Inspector call line or email. information to an individual, agency, or department from another state or, to the extent permitted by federal law, to a Upcoming federal law enforcement agency that would identify an individual and that is related to Meetings an individual seeking or obtaining gender- arming health care, as specied. • The release of medical information related Board and committee meetings are open to the to sensitive services, as dened, in response public; all are encouraged to attend. to a foreign subpoena that is based on a violation of another state's laws authorizing Visit Board and Committee Meetings on the a criminal action against a person or entity Board's website for schedules and information for provision or receipt of legally protected on how to participate in meetings. The site health care activity, as dened. also includes links to agendas and materials for • The issuance of a subpoena based on upcoming meetings as well as links to minutes and recorded webcasts of previous meetings. a violation of another state's law that interferes with a person's right to seek or Notices are emailed to subscribers when obtain gender arming health care or meeting agendas and materials are posted - gender-arming mental health care, as online. To receive notices, visit the email specied. registration page. • The sharing of CURES data with an out-of- Note that meeting schedules may change state law enforcement agency without a throughout the year, so be sure to check the warrant, subpoena, or court order. Board's website for current meeting dates and locations.

Regulations

The California State Board of Pharmacy adopted important new regulations and regulatory amendments that took eect in 2025. Information and the Order of Adoption for each regulation is posted under "Approved Regulations" on the Board's website, www.pharmacy.ca.gov. CCR section 1749(c), Pharmacy Technician Fee Schedule. This amended regulation reduced the pharmacy technician renewal fee starting January 1, 2025. The fee decrease for technicians was made to make it more aordable and help individuals to maintain their license. Fees have been established Compounding Regulation Changes within the statutory range, but at a lower rate than On June 19, 2025, the California State Board of Pharmacy (Board) received notication from the established pre-set amount. The Board voted Oce of Administrative Law (OAL) that the Board's to lower the pharmacy technician renewal fee compounding regulation changes were approved. from $180 to $150 every two years. The fee for the The Notice of Approval provides that the new issuance of a pharmacy technician license is $120, regulations became eective on October 1, 2025. decreased from $195. The penalty fee for failure to renew has been decreased to $75, this is down As required by law, the Board conducted a from $97.50. comprehensive review of its compounding regulations and identied necessary changes CCR section 1793.65, Pharmacy Technician after USP General Chapters1 became compendial. Certication Programs Documents These eorts resulted in the Board voting, as part The amended regulation extends the current of its April 2023 Board meeting, to promulgate certication program sunset date from December new regulations. Since that time, and after ve 31, 2024, to June 30, 2026. This ensures that formal comment periods, a regulation hearing, and the currently approved pharmacy technician extensive review and discussion over the course certication programs continue to serve as a valid of multiple public meetings, the Board completed pathway to licensure for applicants. Eective the formal rulemaking process. With the recent February 4, 2025. approval by the OAL of the updated compounding CCR section 1709.1, Designation of Pharmacist-in- regulations promulgated by the Board, the Board Charge (PIC) wishes to update its stakeholders on its policy This amended regulation requires the proposed related to licensees transitioning to the updated PIC to complete a board-provided training course, USP General Chapters and updated regulations. entitled Pharmacist-in-Charge Overview and Responsibility, within two years prior to the date of During this intervening period, the Board application. Eective April 1, 2025. encourages licensees to continue transitioning to - the new standards established in USP, and to take CCR section 1700, Digital Signatures steps to establish compliance with the Board's This amended regulation allows the Board updated regulations. to accept digital signatures, meeting specic requirements on any written communication, application or other document in which a signature is required or used. Eective July 1, 2025.

Immunization Alert

AB 1503

Changes to administering vaccines will take place at the new year. Assembly Bill 1503 (Berman, Chapter 196, Statutes of 2025) was signed by Governor Newsom and will take eect on January 1, 2026. Under the provisions established in AB 1503, pharmacist authority to independently initiate and administer vaccines for persons three years of age and older will transition to a standard of care practice model. Such an approach is consistent with other health care practitioners with similar practice authority. In anticipation of this change, the Board strongly encourages pharmacists to begin the transition to a standard of care practice model for immunizations for patients three years old and older. The Board intends to use enforcement discretion during this intervening period. The Board also reminds pharmacists that Business and Professions Code section 4052(a)(11) currently provides a pharmacist with the authority to administer immunizations to any person, regardless of age, pursuant to a protocol with a prescriber. This current authority will exist until January 1, 2026, when AB 1503 takes eect. Note that while AB 1503 repeals current subdivision (a)(11) of section 4052, it also adds new subdivision (a)(12), which, eective as of January 1, 2026, provides general authority for a pharmacist to initiate, adjust, or discontinue drug therapy for a patient (which includes vaccine administration) under either (1) a collaborative practice agreement, or (2) under specied conditions, an order or authorization made by the patient's prescriber. (See Stats. 2025, Ch. 196, Sec. 13 (AB 1503), eective January 1, 2026.)

West Coast Health Alliance

Here are recent developments related to vaccines:

• In early September, the West Coast Health Alliance was launched to provide evidence-

based unied recommendations for residents of California, Oregon, Washington, and Hawaii regarding who should receive immunizations.

• On September 17, the California Department of Public Health announced ocial

immunization recommendations in accordance with this Alliance.

• Recent enactment of Assembly Bill 144 (Committee on Budget, Chapter 105, Statutes

of 2025) provides authority for pharmacists to independently initiate and administer to individuals three years of age or older an immunization that, on January 1, 2025, had in eect an ACIP recommendation and that is recommended by the California Department of Public Health. This authority became eective on September 17, 2025, and provides separate and independent authority (complementing other current and forthcoming - authorities) for pharmacists to administer vaccines.

• AB 144 also contains provisions related to Medi-Cal coverage of vaccines and immunizations.

Learn more about Medi-Cal coverage of vaccines here.

Are You Administering the Correct Vaccine?

Remember to Review Patient Consent Form

event stated she overheard the interaction at the front counter with the clerk and she thought she heard the parent say they wanted the u vaccine. If the pharmacist had followed immunization best practices, applicable pharmacy procedures, and the requirements of California pharmacy law prior to administration, this error could have been prevented. Below is an example of a process that complies with best practices and California law: • The pharmacist initiates the immunization process with the patient and answers any questions the patient may have regarding The California State Board of Pharmacy (Board) the vaccine(s). continues to receive complaints about pharmacists • The pharmacy sta obtains the patient not reviewing patient consent forms for consent, including: vaccinations and/or not providing consultation to the patient prior to the administration of a vaccine. o Patient screening questions on current As a result, some patients have received the health conditions, allergies, long-term incorrect vaccine. health conditions, and pregnancy status. In a recent complaint the Board received, a parent and their child went to a pharmacy and o Previous vaccination history (both at asked for the COVID-19 vaccine for each of them. their pharmacy and other locations, The pharmacy sta member checked with the which can be viewed online via the pharmacist on duty and conrmed they could California Immunization Registry provide the immunizations. The parent lled out (CAIR)). their consent forms and documented their request for the COVID-19 vaccine. o Providing the patient with the applicable Vaccine Information When the parent and their child were called into Statement(s). the immunization room, the pharmacist did not • The pharmacy sta processing the conrm their specic patient information (such as name and date of birth), nor conrm which vaccine prescription for the vaccine is a dierent they requested to receive. The vaccines were person than the pharmacy technician, administered without incident; however, after the intern pharmacist, or pharmacist selecting immunization the parent saw on the paperwork the correct product to be used. that they each received the inuenza vaccine and • The pharmacist reviews each consent form -not the COVID-19 vaccine. for appropriateness, veries the correct The investigation revealed both immunization product to be used, and performs a drug prescriptions were typed and prepared for the utilization review. inuenza vaccine by the pharmacist, despite the consent form requesting for the COVID-19 vaccinations. The pharmacist on duty during the

See Correct Vaccine?, Page 9

Correct Vaccine?

Continued from page 8

• Prior to administration of the vaccine: As a reminder: • California Code of Regulations, title 16, o The pharmacist provides consultation section 1707.2 requires a pharmacist to the patient, including common to provide oral consultation to his or side eects, and if they must wait for her patient or the patient's agent in all observation after receiving the vaccine. settings: (1) upon request; (2) whenever

• The person administering the the pharmacist deems it warranted in immunization verbally conrms the the exercise of his or her professional patient's personal information (such judgment; (3) whenever the prescription as name and date of birth), and which drug has not previously been dispensed vaccine they are requesting to receive, to a patient; or (4) whenever a prescription by using open-ended questions. For drug not previously dispensed to a patient example: in the same dosage form, strength or with the same written directions, is dispensed by "Can you please conrm your rst and the pharmacy. last name for me and which vaccine you • California Business and Professions Code are here to receive today?" (BPC) section 4052.8 permits pharmacists In addition, after a vaccine is administered, per to independently initiate and administer California Code of Regulations, title 16, section vaccines under specied conditions. 1746.4, the pharmacist must: • BPC section 4115(b)(1) permits pharmacy • Report the information described in section technicians to prepare and administer 120440, subdivision (c), of the Health and inuenza and COVID-19 vaccines under Safety Code to CAIR within 14 days of the direct supervision and control of a administration. pharmacist under specied conditions. • At the request of a patient, notify the • California Code of Regulations, title 16, patient's primary health care provider of section 1716 states pharmacists shall any vaccines administered to the patient not deviate from the requirements of a (or enter the appropriate information in prescription except upon the prior consent a patient record system shared with the of the prescriber or to select the drug primary care provider, as permitted by the product in accordance with BPC section primary care provider) within 14 days of 4073. administration. If a patient does not have a primary care provider or is unable to The Board strongly encourages pharmacies provide contact information for his or her and pharmacists to evaluate their practices primary care provider, the pharmacist must for initiating, processing, and administering advise the patient to consult an appropriate vaccinations, to ensure their practices are aligned health care provider of the patient's choice. with California pharmacy law, and to ensure -• Provide the patient with a vaccine patients are receiving the correct vaccine product. administration record which fully documents the vaccine(s) administered. An example of an appropriate vaccine administration record is available on the Board's website on the "Vaccinations" page.

CAMER

Reporting Medication Errors

The Institute for Safe Medication Practices (ISMP) will oversee medication error reports under Business and Professions Code (BPC) section 4113.1. The Board advises licensees that medication errors that occurred on or after September 1, 2025, must be reported to the California Medication Error Reporting (CAMER) system. The API that allows for direct, electronic submission of medication errors to the CAMER system is available. If you are interested in implementing the API in your internal reporting system, please email the Institute for Safe Medication Practices at: clientservices@ecri.org. For individual pharmacies that want to implement the API, please include the following information in your communication:

• Pharmacy name (as listed on the pharmacy license) • Pharmacy license number • Conrm this is for an individual pharmacy and the pharmacy is not part of a parent organization

who will be reporting on behalf of the pharmacy. For organizations and Patient Safety Organizations (PSO) that will implement the API to report on behalf of multiple pharmacies, the Board will need to understand the relationships between individual pharmacies and the parent organization and/or PSO. Please include the following information in your communication:

• Name of the parent organization and/or PSO • A list of the pharmacies on whose behalf you will be reporting

• Please provide both the pharmacy names (as listed on the pharmacy license) and license
  numbers

• Please provide details as to the relationship between the individual pharmacies, any multi-
  pharmacy organizations, and your organization Once the Board conrms the information and the correct relationships, if any, between individual pharmacies and parent organizations is established, an API key to use for testing purposes during the organization's internal development process will be issued via encrypted email. - When the organization has completed their internal development and testing, they can contact ISMP for a new API key to use for submission of medication error reports. The API used during development and testing will be discontinued. The API technical documentation to use for development can be found in the Frequently Asked Questions section at: https://mederrors.ismp.org/products/ca-board-of-pharmacy-error-reporting.

From the CAMER Database:

Patient Readmitted to Hospital with Sepsis after Taking only Diluent from Vancomycin Kit

This article was provided by ISMP consistent with the CAMER reporting requirement • Incorporate technology at the point of sale A patient was diagnosed with Clostridium difcile colitis and was prescribed FIRVANQ (vancomycin). to alert pharmacy sta that the prescription To facilitate reconstitution, the product comes in a needs to be reconstituted. Explore options carton containing a bottle of vancomycin powder to utilize an interactive alert, for example, and a bottle of diluent. Prior to dispensing, the one that requires a pharmacist to conrm contents of the drug powder in one of the bottles that the medication has been reconstituted. must be reconstituted with the diluent from the • Add a distinct visual cue to the prescription other bottle. However, in this case, the Firvanq kit receipt indicating that the medication was dispensed to the patient without mixing the needs to be reconstituted prior to diluent with the vancomycin powder. At home, dispensing. the patient took "doses" from the diluent bottle • Do not place the actual product container and therefore did not receive any active drug. The patient's C. difcile infection progressed into sepsis, in the same bag with other prescriptions for and they required hospitalization. the patient as this can make it easier to miss that the product needs to be reconstituted. The brand name, Firvanq, is displayed on both • Provide an appropriate metric-only the powder and diluent bottles. ISMP has previously received reports in which pharmacy dosing device, which corresponds to sta read "Firvanq" on the diluent label and the instructions on the label, with the missed that it was just the diluent. They dispensed prescription. the diluent bottle thinking it contained active • Give the reconstituted product to a drug. In response to these error reports, the manufacturer, Azurity Pharmaceuticals, previously pharmacist. Open the bottle with the revised the diluent bottle container label. They patient or caregiver to check that the made the word "Diluent" more prominent and contents have been reconstituted. deemphasized the brand name, Firvanq, to help • Use the teach-back method to education practitioners recognize the bottle contains diluent patients about the medication. Have the only. However, if the diluent bottle is mistakenly caregiver or patient demonstrate how they dispensed to patients, they may not understand will measure and administer the dose to what diluent means and assume the bottle validate comprehension. contains active drug. To reduce the risk of errors, consider the following recommendations. • Standardize the process used to prepare - and dispense Firvanq (and other medications that require reconstitution). Firvanq MUST be reconstituted prior to dispensing. Do not dispense the Firvanq diluent bottle to the patient or the kit with the powder not reconstituted with the diluent.

Inspection Results

Enforcement and Compounding Committee Releases Report on Inspections

The California State Board of Pharmacy inspection program provides a signicant opportunity for BOP inspectors to educate licensees. Inspections provide an opportunity to observe, evaluate and educate. The Board has established a policy goal to inspect all pharmacies every four years. The BOP provides several tools to help licensees prepare for an inspection, they include: • Ask Inspector Program: licensees can call and ask compliance questions; an inspection FAQ list and a free webinar is available on the website, "How to Prepare for an Inspection", • inspection brochure is available that explains what to expect during an inspection, • articles in The Script newsletter, • and self-assessment forms.

THE INSPECTOR IS THERE TO OBSERVE: Notice to Consumer Poster Consultation Point to Your Language Sign Security Features Procedure Pharmacy Permit Privacy Space Stang Ratio and Pofessional Name Tags (Audio and Visual) Duties Performed Interactions ITEMS TO BE REVIEWED DURING AN INSPECTION: Completion of Compliance in Enrollment in the Self-Assessment Form CURES Reporting Subscriber Alert System

Quality Assurance Policy Policies and Procedures Medication Errors Report WHAT IS INSPECTED: - Cleanliness Expiration Dates Physical Facility Security (Including Labels) Orderliness

See Inspection Reports, Page 13

Inspection Reports

Continued from page 12

Top Corrections on Routine Inspections Chain Pharmacies Violation Description CCR 1714 Operational Standards and Security BPC 4058 License Display CCR 1746.4 Pharmacists Administering Vaccines CCR 1715 Self-Assessment of PHY by PIC CCR 1707.2 Duty to Consult Non-Chain Pharmacies Violation Description CCR 1715.65 Inventory Reconciliation Reports of Controlled Substances CCR 1707.2 Duty to Consult CCR 1714 Operational Standards and Security CCR 1707.5 Patient-Centered Labels CFR 1304.11 Inventory Requirements

Top Written Notices on Routine Inspections Chain Pharmacies Violation Description CCR 1714 Operational Standards and Security CCR 1707.2 Duty to Consult CCR 1715 Self-Assessment of PHY by PIC CCR 1776.1 Prescription Take-Back BPC 4115 Pharmacy Technician; Tasks, Ratios, Supervision Non-Chain Pharmacies Violation Description - CCR 1715.65 Inventory Reconciliation Reports of Controlled Substances CCR 1714 Operational Standards and Security HSC 111330 Labeling BPC 4312 Voiding of License

2024-2025 Fiscal Year

On an annual basis the Board's Enforcement and Compounding Committee receives a presentation on the Board's citation and ne program. Included in the presentation are the most common violations resulting in the issuance of a citation and ne. Pharmacies (PHY) Top Ten Violations Chain Pharmacies Non-Chain Pharmacies Violation Description Violations Description Operational Standards and CCR 1716 Medication Error CCR 1714 Security Operational Standards and CCR 1714 Security BPC 4113 Notify Board Regarding PIC BPC 4113 Notify Board Regarding PIC BPC 4301 Unprofessional Conduct CCR 1735 Compounding - Related CCR 1764 Disclosure of Medical Erroneous or Uncertain CCR 1761 CCC 56.10 Information Prescription CCR 1707.2 Duty to Consult CCR 1715 PIC Self-Assessment Obstruction/Delay in Operate for more than 30 days BPC 733 BPC 4305 Therapy without PIC Pharmacy Technician; Tasks, BPC 4115 CCR 1716 Medication Error Ratios, Supervision BPC 1711 Quality Assurance BPC 4059 Rx Requirements Osite storage CCR 1707 BPC 4081 Records Maintenance Requirements Eective January 1, 2022, the Board was given authority under BPC section 4317.5 to bring an action for nes for repeated violations of materially similar provisions of the Pharmacy Law within ve years by three or more pharmacies operating under common ownership or management within a chain community pharmacy, as follows: a third and, or subsequent violation may be punished by an administrative ne not to exceed one hundred thousand dollars ($100,000) per violation. -Additionally, under the same section the Board may bring an action against a chain community pharmacy operating under common ownership or management for nes not to exceed one hundred fty thousand dollars ($150,000) for any violation of the Pharmacy Law demonstrated to be the result of a written policy or which was expressly encouraged by the common owner or manager.

See Citations Issued, Page 15

Continued from page 14

Violations Issued Under Authority of 4317.5 (a) Violations Issued Under Authority of 4317.5 (b) Violation Description Violation Description BPC Quotas Established by Chain CCR 1716 Medication Error 4113.7(a)(b) Pharmacy Unlawful Dispensing of Dangerous BPC 4113 Notify Board Regarding PIC BPC 733 Drugs and Devices/Obstruction Operate for more than 30 days BPC 4305 CCR 171 Pharmaceutical Practice without PIC CCR 1707.2 Duty to Consult

Click here to review the June 2025 Citation Presentation at the Enforcement Committee Meeting.

Pharmacist in Charge Training Webinar

Pharmacist-in-Charge training webinar is available on the California State Board of Pharmacy website. This webinar provides an overview of pharmacy law related to the position and the responsibility of a pharmacist when associating as the Pharmacist-in-Charge of a licensed facility. Additionally, the webinar has tips on how to prepare for an inspection and provides resources for the PIC to use in their supervision and management of a pharmacy. One hour of CE will be awarded for completing the webinar training; however, it does not count toward the required 2 hours of CE for Law and Ethics. - To take this course you must sign up for a PharmED account. Click here to sign up for an account or use this link: https://pharmed.thinkic.com/

Striking the Right Balance:

Technology and the Pharmacist's Role in Medication Safety

The investigation revealed multiple points of failure:

• The dispensing robot's cassette was

incorrectly lled withAtenolol 50 mgtablets, due to a returned-to-stock bottle that had been mislabeled.

• During the pharmacist's verication, the

mixed contents of the bottle were not identied, and the verication image did not raise concerns due to similarities in tablet color and shape.

• The prescription was a rell, and no

Technology continues to transform health care, consultation was oered, removing the oering new tools to support patient safety nal opportunity to correct the error. and enhance pharmacy operations. From electronic prescribing and real-time access This incident highlights the importance of to patient medication histories, to the use of robust policies and procedures for managing automated dispensing devices and robotics, these returned-to-stock medications and automated advancements can signicantly improve eciency dispensing systems. Pharmacy personnel must be and accuracy in the medication-use process. thoroughly trained on proper handling practices, and pharmacists should always perform a visual While automation and digital systems play a check of medication contents--especially from critical role in supporting workow, they are not automated systems. a replacement for a pharmacist's professional judgment. Pharmacist oversight remains essential Pharmacists are uniquely positioned to serve at every stage of the dispensing process--from as the nal safeguard in preventing medication inventory management to nal verication and errors. Technology should enhance--not replace-- patient consultation. their ability to provide safe and eective patient care. The Board recently investigated a case involving a dispensing error linked to the improper The Board encourages all pharmacies to evaluate use of automated technology. A patient their current use of technology, ensure sta are received a prescription bottle that contained properly trained, and reinforce a culture of safety bothFurosemide 40 mgtablets andAtenolol and patient-centered care. -50 mgtablets, dispensed by a robotic system. The patient began taking the medication before realizing the tablets looked dierent, ultimately reporting side eects after consuming an unknown quantity of the incorrect drug.

Albuterol and Epinephrine

Standing Orders for Schools

California schools are authorized standing orders for epinephrine, quantities of 25 per school site. to stock unassigned albuterol albuterol, and disposable spacers Schools may request rells if metered-dose inhalers (MDIs), as the authorizing physician. devices are used or become single-use disposable spacers, Standing orders are issued to inoperable. and epinephrine auto-injectors schools under the name of the For the Epinephrine Standing for emergency use. school and medications are not Order, schools may request up assigned to any specic student The California Department to four auto-injectors per site. or sta. The standing order of Public Health (CDPH) has Schools may request either or features a box which contains issued statewide standing both standard and junior dose all required information to ll an orders that enable all California auto-injectors (depending order including medications and TK-12 public, charter, and on their school population) quantities, which looks similar to private schools, as well as local in multiples of two. Rells are a prescription. education agencies (school allowed if devices are used or if districts), and county oces Local education agencies (school they become inoperable. of education, to obtain MDIs districts) and county oces of To learn more about program and single-use disposable education may place orders on eligibility, training requirements, spacers, as well as epinephrine behalf of multiple schools under and how schools can apply auto-injectors without an their jurisdiction. or renew, please visit the independent physician's For the Albuterol Standing CDPH website or contact the prescription. Order, MDIs may be obtained Oce of School Health at Dr. Erica Pan, California's State in quantities of two per school SafeSchoolsTeam@cdph.ca.gov  Public Health Ocer, issued site and disposable spacers in

Report a Drug Theft/Drug Loss

Online Portal

The Board of Pharmacy has launched a new online portal for reporting the theft or loss of controlled substances. Using this portal ensures that all required information, as outlined in California Code of Regulations, Title 16, §1715.6, is accurately -submitted.While the portal use is not mandatory, we strongly encourage utilizing it for future reports. Please nd the link below. https://www.pharmacy.ca.gov/webapplications/ apps/drug_loss/index.shtml

Board Welcomes New Members

The California State Jeanette Dong was appointed to the would like to welcome California Board of Claudia L. Mercado. Pharmacy as a Public Mercado is a public Board Member by the member and was California Speaker appointed by the of the Assembly in California Senate Rules 2025. Member Dong Claudia L. Mercado Jeanette Dong committee. Mercado is currently the Chief previously served for Strategy Ocer for nearly 11 years on the Osteopathic Medical Board Alameda Health System. of California. Member Dong has held positions with the Mercado is the founder of Vervida, a mineral California State Assembly, Alameda County, supplement brand, and Calibueno, a cannabis The Port of Oakland and Asian Health Services/ company. La Clinica de la Raza. Member Dong has served with the California Board of Registered Nursing, Mercado earned a Master of Business California Public Health Advisory Committee, Administration and Bachelor of Arts from Mills California Public Utilities Commission Workforce College. Development Task Force and the California Health and Wellness Task Force (SDE) and numerous other Her term will expire June 1, 2028. appointments in San Francisco and Oakland. Member Dong graduated from University of California, Berkeley, and received her master's degree from Columbia University. She was also an APPAM Sloan Fellow at Harvard University and a Coro Foundation Fellow. Her term will expire June 1, 2028. Board Honors 40-Year Pharmacists

Congratulations Member Sandhu

The Board would like to congratulate Satinder Sandhu for his commitment to serving California patients for 40 years. The Board would also like to congratulate all pharmacists that have met this milestone. Thank you for your commitment to California -consumers. As a reminder, pharmacists that have reached this milestone are welcome to attend a Board meeting for receive more formal recognition by the Board and receive a pin. Click here for a list of all pharmacist who have served as a provider for 40 years. https://www.pharmacy.ca.gov/licensees/personal/40yr_rph.shtml

Well-Being Index

Mental Health Support

The American Pharmacist Association (APhA) The California State Board of Pharmacy would like monitors data from the Well-Being Index to to remind licensees that there are a wide range of determine a "distress percent" for pharmacy free mental support resources, most of which are personnel based on pharmacy personnel who online. score a well-being index greater than or equal to 5, The Pharmacist Well-Being Index is a validated, which indicates a risk of high distress. self-assessment tool created by the Mayo Clinic According to APhA, pharmacy personnel who are and launched in 2019. Participants can log on at high risk of distress also have: via website or phone app and answer questions intended to assess several dimensions of distress • a three-fold higher risk of low quality of life and well-being related to work - including quality of life, fatigue, burnout, concern for a recent major • an eight-fold higher risk of burnout medication error, and intent to leave the current job. • a 2.5-fold higher risk of high fatigue The tool is available to pharmacists, student • a 2.5-fold higher risk of intent to leave their pharmacists, and pharmacy technicians. Users can job retake the assessment and track their well-being

• a two-fold higher risk of medication error over time. All answers are anonymous. According to the index website, "All data is stored in secure The interactive online tool allows pharmacists to cloud servers and provided to administrators in a anonymously measure their well-being in less than de-identied aggregate format." one minute, access custom resources, compare their scores to peers' and national averages, and In addition, the index provides resources to assist track their progress over time. users whose responses indicate risk of distress. The data collected also enable organizations to collect information to pinpoint causes of distress and make meaningful changes to maximize the mental health of participants.

Check and See: Is it an Authorized Dealer?

Diabetic Test Strips

Diabetic test strips must only be purchased from an authorized seller. Business and Professions Code (BPC) section 4160.5, requires manufacturers of nonprescription diabetes test devices to post the names - of their authorized distributors on the internet and to make those names available for posting on the California State Board of Pharmacy website. "Nonprescription diabetes test device" means a glucose meter or test strip for use in the treatment of prediabetic or diabetic individuals that may be sold without a prescription and that is labeled for use by the consumer in accordance with the requirements of the laws and rules of this state and the federal government.

Disciplinary Terms Explained

Voluntary Surrender - The licensee has agreed Accusation - An accusation is the document to surrender his or her license, and the right containing the charges and allegations of to practice or operate a Board-licensed entity violations of the law that is led when an agency is seeking to discipline a licensee. is ended. The Board May agree to accept the surrender of a license through a "stipulation" or Eective Date of Action - The date the agreement. disciplinary action goes into operation. Suspension - The licensee is prohibited from Revocation or Revoked - The license is taken practicing or from operating a Board-licensed back by the Board as a result of disciplinary action, entity for a specic period of time. and the licensee's right to practice or operate a Suspension/Probation - The right to practice or Board-licensed entity is ended. operate is contingent on compliance with specic Revoked, Stayed - The license is revoked, but the terms and conditions during the probationary revocation is not eective as long as the licensee period, including a term of suspension. complies with specic probationary conditions, PC 23 Order Issued - The licensee is restricted which May include a temporary suspension of the from practicing or operating by the terms of a licensee's right to practice. court order issued under the provisions of Penal Stipulated Settlement - The Board and a licensee Code section 23. mutually agree to settle a disciplinary case brought Public Reprimand - Resulting from a disciplinary by the board by way of a settlement agreement. action, the licensee is issued a letter of public Stayed - The revocation or suspension action is reprimand. not immediately eective, and the operation or Reinstatement of License - A previously revoked practice May continue so long as the licensee fully complies with any specied terms and conditions. or suspended license is reinstated with or without specied terms and conditions. Probation - The licensee May continue to practice Statement of Issues - A legal document that or operate a board-licensed entity under specic details the factual or legal basis for which a license terms and conditions for a specic period of time. was denied.

Disciplinary actions: January 1 - June 30, 2025

Disciplinary Actions for Unprofessional Conduct. Qlarant Jan. 1, 2025 - March 31, 2025 Eective 3/28/2025. investigation - Acts Involving Personal Licenses Alkazaki, Usama, RPH 69696, Ah Mu, Kiana R., TCH 187438, AC 7033 AC 7773 - Insurance Fraud; Subvert Pilot Hill, CA or Attempt to Subvert an investigation - Acts Involving Investigation; Incorrect Labeling; of Substantially Related Crime; Latuda Investigation - Making or Signing Document that

See Disciplinary Actions, Page 21

Continued from page 20 Insurance Fraud; Subvert Corruption; Acts Involving Moral

Falsely Represents; Insurance or Attempt to Subvert an Fraud; Unprofessional Conduct. Investigation; Incorrect Labeling; Deceit, or Corruption. La Maestra investigation - Acts Involving Dishonesty, Latuda Investigation - Making Fraud or Deceit; Making or or Signing Document that Signing Document that Falsely Falsely Represents; Insurance Represents; Insurance Fraud; Fraud; Unprofessional Conduct. Bajaj, Harminder, RPH 62181, Unauthorized Prescriptions; La Maestra investigation - AC 7367 Forgery; Subvert or Attempt Acts Involving Dishonesty, Millbrae, CA Fraud or Deceit; Making or Incorrect Labeling; Adulterated Signing Document that Falsely Drugs; Unprofessional Represents; Insurance Fraud; Conduct. La Mesa Cardiac Unauthorized Prescriptions; investigation - Acts Involving Forgery; Subvert or Attempt Incorrect Labeling; Adulterated Prescriptions; Incorrect Labeling; Drugs; Unprofessional Conduct. La Mesa Cardiac Patient investigation - Incorrect investigation - Acts Involving Labeling; Unprofessional Conduct; Acts Involving Prescriptions; Incorrect Labeling; Failure to Keep Protected Information Secure; Failure to that Falsely Represents; Incorrect Patient investigation - Incorrect Keep Dangerous Drugs Secure Labeling; Unprofessional in the Pharmacy; Failure to Store Subvert an Investigation; Cash Conduct; Acts Involving Controlled Substances Securely; Failure to Include Required Information on Controlled that Falsely Represents; Incorrect Substances Biennial Inventories; Failure to Appropriately Label Subvert an Investigation; Cash Dangerous Drugs Held for Sale in Pharmacy; Failure of PIC to Document Annual Review Alkazaki, Usama, APH 10659, of Compounding Policies AC 7033 & Procedures; Adulterated/ Expired Drugs in Active Stock; Failure to Notify the Board of a investigation - Acts Involving Loss in Controlled Substances; Arias, Steven Omar, TCH 83080, Failure to Notify Drug Delivery - AC 7754 Patients of Right to Consultation; Monrovia, CA Furnishing Compounded Drug Preparation to Physician Convictions of Substantially Oce with Insucient Unprofessional Conduct. Qlarant Related Crimes - November 27, Documentation; Failure to investigation - Acts Involving 2023, Lewd or Lascivious Acts: Maintain Documentation re Child Under Age 14, Two Counts;

See Disciplinary Actions, Page 22

Failure to Notify the Board of

Continued from page 21 Change of Address within 30

days; Unprofessional Conduct. Cleaning of Compounding Facilities and Equipment; Failure to Report Sales of Compounded Chicas, Raquel Araya, Controlled Substances to CURES; TCH 167243, AC 7842 Unprofessional Conduct re Cudahy, CA Administration of COVID-19 Vaccines by Medical Assistants. Cabral, Kirstin M., TCH 174988, Conviction, Burglary; Act AC 7805 18 months subject to the terms Use of Alcoholic Beverages in Manner Dangerous to Public. Baluyot, Ryan Narag, TCH 105509, AC 7863 Chiu, Peter W., RPH 30425, American Canyon, CA AC 7367 Millbrae, CA Unprofessional Conduct; Act of Chang, Long-Shyang, RPH 62419, AC 7741 Fraud, Deceit, or Corruption; Irvine, CA False Statement. Unprofessional Conduct - Furnishing Dangerous Drug without Prescription of Qualied Professional; Fraud; Benton, Crystal L., TCH 167930, Knowingly Making a Certicate AC 7712 or Document That Falsely Faireld, CA Represents the Existence of a State of Facts; Inappropriate Unprofessional Conduct - Exercise of Education, Training, Variation from a prescription; Dangerous Use of Alcoholic and Experience As a Pharmacist; Multiple Allowable Beyond Use Beverages; Unprofessional Failure to Exercise Best Dates Stated on Master Formula/ Conduct - Criminal Conviction. Professional Judgment. Compounding Record. license is placed on probation for one year subject to the terms Chiang, Cristy Yueh Lui, TCH 72129, AC 7857 - San Francisco, CA Brady, Alphonsus Michael, Choi, Julie Miae, RPH 56120, RPH 71414, AC 7690 Unprofessional Conduct-Moral AC 7869 Torrance, CA Cause for discipline: Use Deceit, and/or Corruption; Cause for discipline: Driving of Alcoholic Beverages in a Submission of Renewal with Under the Inuence; Dangerous Dangerous or Injurious Manner; False Information; Criminal See Disciplinary Actions, Page 23

Statement of Issues Withdrawn Eective January 13, 2025 Continued from page 22 Conviction for Insurance Fraud; Fatouh Albana, Mary, TCH 79154, Dishonest Act, lied under oath; AC 7841 Making Statement that Falsely Represents Facts. Conviction for DUI; Alcohol- Related Criminal Conviction; Cisneros, Angela E., TCH 187004, AC 7714 Deis, III, John J., EXC 26584, AC 7582 Figueroa, Julian, TCH 148457, Conviction for Insurance Fraud; AC 7824 Dishonest Act, lied under oath; Santa Ana, CA Making Statement that Falsely Represents Facts. Conviction for Arranging a Meeting with a Minor with Eective 2/21/2025. the Intent to Commit a Sexual Cisneros, Ricardo, TCH 59072, Oense; Acts Involving Moral AC 7715 Turpitude. Tujunga, CA Demirchyan, Kachatur Chris, Act Involving Moral Turpitude TCH 181607, AC 7822 Action: The Accusation is Flores Moroyoqui, Rosario D., dismissed. TCH 175322, AC 7607 Eective 3/20/2025. of a Substantially Related Crimes; Fontana, CA Violated Statutes regulating Cortez-Gomez, Brenda O., controlled substances and RPH 67947, AC 7033 Convictions of Substantially dangerous drugs; Acts Involving Chula Vista, CA Related Crimes; Dangerous Use of Alcohol. Fraud, or Deceit. investigation - Unauthorized Prescriptions; Unprofessional Conduct. La Mesa Cardiac investigation - Uncertain Prescription; Unprofessional Conduct. Dulin, Matthew W., Applicant, - Statement of Issues Case SI 7817 Fong, So-Sheung, RPH 47613, Pine Grove, CA AC 7457 of a Crime; Violation of Statutes Regulating Controlled Deis, III, John J., TCH 42663, Inadequate Policies and Substances. AC 7582

See Disciplinary Actions, Page 24

Cause for discipline: Act Involving Moral turpitude, Conviction for "Wet Reckless" Continued from page 23 Dishonesty, Fraud, Deceit or Driving; Dangerous Use of Procedures; Inaccurate Beyond Corruption; Conviction of Controlled Substances; Violation Use Dates for Compounding Substantially Related Crime. of State Laws Regulating Sterile Drug Preparations; No Controlled Substances; Record of Beyond Use Dates for Sterile Compounded Drug Preparations; No Immediate Use Label for Medium Risk Sterile Khan, Adnan A., TCH 197284, Compounded Drug Preparations; AC 7865 No Record of Date Compounded decision. Carmichael, CA for Sterile Compounded Drug Preparations; Failure to Follow Unprofessional Conduct: Kurniawan, Brandon John, Pharmacy's Written Policies and Dishonest Acts; Unprofessional RPH 81262, AC 7862 Procedures; Failure to Notify Conduct: Self-Administering Rancho Cucamonga, CA Board Ceasing to Act as PIC. a Controlled Substance; Unprofessional Conduct: Conviction, Attempted First Violating a Statute Regulating Degree Residential Burglary; Controlled Substances. decision. Grewal, Amritpal S., RPH 52888, AC 7684 Kohanpour, Ashkan Shawn, Corona, CA RPH 56067, AC 7558 Cause for discipline: Illegal Possession of a Controlled Substance/Dangerous Drug; Conviction - Aiding and Lavarias, Jerome Vincent, Dangerous Use of Drugs; General Assisting in the Preparation of TCH 171096, AC 7860 a False Tax Return; Commission Fremont, CA of Any Act Involving Moral or Injurious Use of Alcohol; or Deceit; Knowingly Making Conviction of Misdemeanors Hur, David D., RPH 62156, or Signing Any Certicate or Involving Consumption AC 7716 Other Document that Falsely of Alcohol; Conviction of Dublin, CA Represents the Existence or Substantially Related Crimes. Nonexistence of a State of Facts; of Substantially Related Crime; Revocation, Suspension, or Other Discipline by Another State. Moral Turpitude. - Mangeac, Silviu E., TCH 163855, AC 7873 Roseville, CA James, Charles Michael, Krause, Laura M., TCH 60142, TCH 102179, AC 7743 AC 7669 Salinas, CA Alcohol; Conviction of a Crime

See Disciplinary Actions, Page 25

Regulating Controlled Substances. Continued from page 24 Involving Alcohol. Nguyen, Van Nhu, RPH 66262, AC 7629 Muniz, Tiany N., TCH 199661, Yucaipa, CA SI 7912 Manriquez, Almariejoy A., Beaumont, CA Unprofessional Conduct TCH 173283, AC 7890 Cause for denial: Conviction for - Dishonesty; Violations Stockton, CA DUI with Injury. of Controlled Substance Action: The Application for a Statutes; Unlawful Possession of a Crime; Acts Involving Moral Pharmacy Technician License of a Controlled Substance; Turpitude; Falsely Representing is granted. Upon satisfaction Prescribing Controlled Substance the Existence or Nonexistence of of all statutory and regulatory for Self; Disciplinary Conditions a State of Facts. requirements, the license is of Probation of Pharmacist. issued, immediately revoked,

McCalister, Tiaira S., TCH 36429, Norris, David Colahan, AC 7451 RPH 47155, AC 7803 Visalia, CA Mused, Anwer A., TCH 198978, Stockton, CA SI 7924 of a Crime; Acts Involving Moral Ceres, CA Unprofessional Conduct: Deceit, or Corruption. Action: The Application for a Fraud, Deceit, and/or Corruption; Pharmacy Technician License Knowingly Making or Signing is granted. Upon satisfaction Documents that Falsely of all statutory and regulatory Represent the Existence or requirements, the license is Nonexistence of a State of Facts. issued, immediately revoked, McNease, Joette L., TCH 157144, AC 7769 Lakeside, CA Pedalino, Anthony E., RPH 66342, for Driving Under the Inuence; AC 7515 Negrete, Kristina Jolene, TCH 79710, AC 7725 Goleta, CA Conviction for Wet Reckless; - Criminal Conviction for Disobeying Court Order; McComb, Elisa G., TCH 35895, AC 7834 Knowingly Made a False Stockton, CA Statement of Fact; Acts Involving of Crime; Violation of statutes Fraud, or Deceit. See Disciplinary Actions, Page 26

Stephens, Ahjanae S., TCH 170399, AC 7783 Continued from page 25 Reyes, Leslie, TCH 181466, AC 7378 Conviction; Acts Involving Moral Turpitude. Unprofessional Conduct - Pedalino, Anthony E., APH 10335, AC 7515 General Unprofessional Conduct. Tran, Benjamin, TCH 96736, Conviction for Wet Reckless; AC 7699 Criminal Conviction for Elk Grove, CA Sanchez, Collin K., RPH 60885, Disobeying Court Order; Cause for discipline: General AC 7780 Riverside, CA Dangerous Use of Controlled Substance; Substantially Related Conviction for Child Abuse; Moral Turpitude; Knowingly Making a False Statement. Rahimi, Shapoor, RPH 70570, Valencia, Erik, EXC 25974, AC 7630 two years subject to the terms AC 7831 Sherman Oaks, CA Visalia, CA to Exercise Corresponding Conviction; Multiple Alcohol Sandoval, Erika, TCH 171740, Responsibility; Unprofessional Related Convictions; Dangerous AC 7905 Conduct, Violating Regulation Whittier, CA Applicable to Pharmacy; Misuse of Education. Valley, Scott John, RPH 51595, surrendered. AC 7770 Monrovia, CA Rahman, Navid A., RPH 53027, Scott, Kelly Ann, TCH 12258, AC 7487 - DUI; Dangerous Use of Alcohol; AC 7776 Brentwood, CA Multiple Convictions Involving Cause for discipline: Incorrect the Use of Alcohol. Labeling of Dispensed Conviction for DUI; Dangerous Medications; Conviction of - Substantially Related Crime. Action: The probation previously ordered on license shall be extended for an additional four years subject to the terms period of nine months from the date of execution subject to terms and conditions in the See Disciplinary Actions, Page 27

Wimenta, Ingrid, TCH 61424, AC 7510 Continued from page 26 Pasadena, CA Vasquez, Juan D., TCH 96989, AC 7900 Compounding Drugs While South Pasadena, CA Under the Inuence; Prohibition on Prescribing Controlled Substances for Self. Failure to Keep Protected Alcohol Related Convictions Information Secure; Failure to Keep Dangerous Drugs Secure Eective 3/20/2025. in the Pharmacy; Failure to Store Wyatt, Donald R., Applicant, SI Controlled Substances Securely; 7762 Failure to Include Required Information on Controlled Villaneda, Lilianna, TCH 178723, Substances Biennial Inventories; AC 7772 Action: The Application for a Failure to Appropriately Label Pharmacist License is granted. Dangerous Drugs Held for Sale Upon satisfaction of all statutory in Pharmacy; Failure of PIC Unprofessional Conduct - and regulatory requirements, the to Document Annual Review Commission of Act Involving license is issued, immediately of Compounding Policies Moral Turpitude; Criminal revoked, the revocation stayed, & Procedures; Adulterated/ and the license is placed on Expired Drugs in Active Stock; Failure to Notify the Board of a Loss in Controlled Substances; Failure to Notify Drug Delivery Patients of Right to Consultation; Furnishing Compounded Vu, Vicky K., RPH 57654, AC 7662 Yang, Melissa P., TCH 101302, Drug Preparation to Physician Fullerton, CA AC 7866 Oce with Insucient San Jacinto, CA Documentation; Failure to Maintenance of Records of Maintain Documentation re Dangerous Drugs and Devices; Conviction for Driving Under Cleaning of Compounding Current Inventory; Dishonest, the Inuence; Alcohol-Related Facilities and Equipment; Failure Fraudulent, Deceitful and Criminal Conviction; Dangerous to Report Sales of Compounded Corrupt Acts; Knowingly Making Use of Alcohol; Unprofessional Controlled Substances to CURES; or Signing False Documents; Conduct. Unprofessional Conduct re Operational Standards; Administration of COVID-19 Misbranded and Adulterated Vaccines by Medical Assistants; Drugs; No Biennial Inventory Variation from a Prescription; of Controlled Substances; Multiple Allowable Beyond Use Conducting Business with No Dates Stated on Master Formula/ Facility Licenses Pharmacist-In-Charge. Compounding Record. - Care4U Pharmacy, PHY 56024, AC 7367 Daly City, CA 18 months subject to the terms

See Disciplinary Actions, Page 28

pharmacy shall be sold or closed.

Continued from page 27 Unprofessional Conduct: Qlarant

Palm Care Pharmacy, PHY 56207, Central Rx Pharmacy, PHY 55855, Investigation - Making or AC 7033 AC 7487 Signing Document that Falsely National City, CA Brentwood, CA Represents; Insurance Fraud; Cause for discipline: Molina Cause for discipline: Incorrect Subvert or Attempt to Subvert Investigation - Acts Involving Labeling of Dispensed an Investigation; Incorrect Medications; Incomplete Labeling; Unprofessional Inventory and/or Records of Conduct: Latuda Investigation Acquisition and/or Disposition; - Acts Involving Dishonesty, Inadequate Security. Fraud or Deceit; Making or Signing Document that Falsely Unprofessional Conduct: Qlarant Represents; Insurance Fraud; Investigation - Making or Unprofessional Conduct: La Signing Document that Falsely Maestra Investigation - Acts Represents; Insurance Fraud; Involving Dishonesty, Fraud CVS Pharmacy #16092, Subvert or Attempt to Subvert or Deceit; Making or Signing PHY 53972, AC 7259 an Investigation; Incorrect Document that Falsely Woonsocket, RI Labeling; Unprofessional Represents; Insurance Fraud; Conduct: Latuda Investigation Unauthorized Prescriptions; Prohibited Acts- Administration - Acts Involving Dishonesty, Forgery; Subvert or Attempt of Adulterated Vaccines; Fraud or Deceit; Making or Unprofessional Conduct; Fraud; Signing Document that Falsely Incorrect Labeling; Adulterated Quality Assurance Program; Represents; Insurance Fraud; Drugs; Unprofessional Supervision of Intern. Unprofessional Conduct: La Conduct; Acts Involving Maestra Investigation - Acts Dishonesty, Fraud or Deceit: La Involving Dishonesty, Fraud Mesa Cardiac Investigation - or Deceit; Making or Signing Document that Falsely Prescriptions; Incorrect Labeling; Represents; Insurance Fraud; Unprofessional Conduct: Patient Innity Pharmacy, PHY 57173, Unauthorized Prescriptions; M.A. Investigation - Incorrect AC 7630 Forgery; Subvert or Attempt Labeling; Unprofessional Culver City, CA Conduct: Patient F.S. Incorrect Labeling; Adulterated Investigation - Acts Involving to Exercise Corresponding Drugs; Unprofessional Responsibility. Conduct; Acts Involving Dishonesty, Fraud or Deceit: La that Falsely Represents; Incorrect Mesa Cardiac Investigation - Subvert an Investigation: Patient Prescriptions; Incorrect Labeling; A.A. Investigation - Incorrect Unprofessional Conduct: Patient Palm Care Pharmacy, PHY 53746, Labeling; Subvert or Attempt M.A. Investigation - Incorrect AC 7033 -Labeling; Unprofessional Unprofessional Conduct: Cash Conduct: Patient F.S. Cause for discipline: Molina Investigation - Acts Involving Investigation - Acts Involving surrendered. The eective date shall be stayed until April that Falsely Represents; Incorrect 26, 2025, at which time the

See Disciplinary Actions, Page 29

Highland, CA

Continued from page 28 to Comply with Operational

Andrade, Unique, TCH 151102, Standards and Security. AC 7826 Subvert an Investigation: Patient Downey, CA A.A. Investigation - Incorrect Labeling; Subvert or Attempt a period of two years subject to Unprofessional Conduct: Cash Alcohol Related Convictions. surrendered. The eective Disciplinary Actions for date shall be stayed until April 26, 2025, at which time the April 1, 2025 - June 30, 2025 pharmacy shall be sold or closed. Personal Licenses Eective 5/14/2025. Acosta III, Jesse, TCH 164536, Baez, Stephanie, TCH 168261, Walgreens #04724, PHY 53111, AC 7848 AC 7876 AC 7425 Bakerseld, CA Long Beach, CA Antioch, CA Cause for discipline: Unlawful Cause for discipline: Variation Conviction, Battery; Dangerous Possession of a Controlled from a Prescription; Failure to Use of Alcoholic Beverages; Substances and Dangerous Maintain Operational Standards; Commission of Any Acts Drugs Without a Prescription; Failure to Timely Report Drug Involving Moral Turpitude Loss and Security; Failure to Fraud, Deceit, or Corruption; Compile Inventory Reconciliation Obtained Controlled Substances Reports regarding Controlled by Fraud, Deceit, Subterfuge, Substance. or Concealment of Material decision. Fact; Violations of Controlled Substance Statutes. Adolfo, Ralph Jez S., TCH 154979, Walgreens #02445, NRP 1949, AC 7854 AC 7425 Loma Linda, CA Orlando, FL Cause for discipline: Variation Use of Alcoholic Beverages; from a Prescription; Failure to Maintain Operational Standards; Bates, Nori Jean, TCH 21147, Failure to Timely Report Drug AC 7653 Loss and Security; Failure to Nevada City, CA Compile Inventory Reconciliation Reports regarding Controlled Alfaro, George Juan, TCH 83932, Substance. AC 7811 - Daly City, CA Substantially Related Criminal probation for one year subject to Walgreens Co., dba Walgreens Alcohol. decision. #05300, PHY 52866, AC 7739

See Disciplinary Actions, Page 30

Edema, Adeola O., RPH 63688, AC 7527 to Cooperate with Board Sta; Continued from page 29 Clovis, CA Failure to Report to the Board; Cabrera, Anne Roberto, Cause for discipline: Holding Failure to Interview with the RPH 40776, AC 7187 Expired and Adulterated Board; Failure to Comply with Medications; Prohibited Reimbursement of Board Costs; Acts, Dispensing of Expired Failure to Comply with Clinical or Uncertain Prescriptions; Medications; Failure to Complete Diagnostic Evaluation; Failure to Furnishing Dangerous Drugs a Controlled Substance Comply with Drug and Alcohol without a Prescription. Inventory; Failure to Conduct Testing; Failure to Attend Required Quarterly Schedule II Substance Abuse Recovery Controlled Substance Inventory Relapse Prevention and Support Reconciliation; Failure to Groups. Transmit a Controlled Substance Prescription to CURES; Acts

Corruption; Knowingly Making Casaburi, Susan, TCH 160656, Gapuz, Robert Paul, RPH 72512, or Signing False Documents; AC 7785 AC 7827 Conduct that Subverts an Lake Isabella, CA Stockton, CA Investigation of the Board; Excessive Furnishing of a - DUI; Dangerous Use of Alcohol. of Crime; Dangerous Use of Controlled Substance; Excessive Alcohol. Furnishing of a Controlled Substance; Unauthorized Prescription; Maintenance of Records. Catellanos, Yesenia, TCH 158760, AC 7916 Delano, CA Gardner, Jr., Asa, INT 49265, the decision.Dishonest Act; Violation of AC 7896 Eective 4/7/2025. Statutes. Paso Robles, CA Estrada, Brittany Amber, TCH 161692, AC 7856 Reedley, CA Eective 4/3/2025. Alcohol Related Convictions. Chae, Warren Sooyoung, Use of Alcoholic Beverages in RPH 58955, AC 7879 Manner Dangerous to Public. Corona, CA Cause for discipline: Violation - of probation. Glick, Kevin Craig, RPH 38132, AC 7843 Lihue, HI Estrada, Diana, TCH 71807, Assignment of Unsupported AC 7932 Bakerseld, CA

See Disciplinary Actions, Page 31

Torrance, CA Jones, Jerey La Barron, TCH 12566, AC 7940 Continued from page 30 Antioch, CA Possession of Controlled Substances Without Prescription; Possession of Controlled Substance by Fraud or Deceit.

Houston, Damon, TCH 171185, AC 7603 Kanwar, Anil, RPH 81880, AC 7618 Use of Alcohol; Moral Turpitude; Orange, CA to Maintain Records of Hall, Robert Dale, RPH 29479, Dangerous Drugs; Failure to AC 7187 Maintain Current Inventory of Suamico, WI Dangerous Drugs; Furnishing of Hutchison, Vincent Raymond, Dangerous Drugs to Pharmacies; TCH 100749, AC 7861 or Uncertain Prescriptions; Fowler, CA Records and Inventory: Records Relating to Dangerous Drugs and of Crime; Dangerous Use of Devices; Inventory Reconciliation Alcohol; Unprofessional Conduct. Report of Controlled Substances; Fraud, or Corruption; Furnishing Dangerous Drugs without a Prescription; Failure to Take decision. Lucente, Patricia, TCH 171521, Ensure Compliance with AC 7883 Pharmacy Law; Dispensing Camarillo, CA Dangerous Drugs Out of State Jimenez, Brigitte Alcala, without a License; Erroneous or TCH 185647, AC 7735 Uncertain Prescriptions; Records American Canyon, CA of Acquisition and Disposition Cause for discipline: Acts of Dangerous Drugs and Devices; Furnishing Dangerous Dishonesty, Fraud, Deceit Drugs without a Prescription; or Corruption; Furnishing of Unprofessional Conduct: Moral Dangerous Drug; Possession Turpitude, Dishonesty, Fraud, or of Controlled Substance; - Obtaining Controlled Substance by Fraud, Deceit or Subterfuge; Montes, Eric, TCH 115373, Statement of Issues Case SI 4357 Heimforth, Rayanne Helen, Convictions; Use of Alcohol to an TCH 172212, AC 7852

See Disciplinary Actions, Page 32

Nourani, Noushin, TCH 54497, Security Act; Inappropriate AC 7902 Exercise of Education, Training Continued from page 31 or Experience; Unprofessional Extent or in a Manner Dangerous Conduct to Seif or Others. Dishonesty, Fraud, Deceit; The Application for a Pharmacy Violation of Laws Governing the revocation stayed the license Technician License is granted. Controlled Substances; Violation is placed on probation for four Upon satisfaction of all of Laws Governing Pharmacy. years subject to the terms and requirements, Action: The license is issued, revoked, stayed, and placed on probation for three Patel, Shekha Dashrath, years subject to the terms and Orozco, Sara Lynn, TCH 135464, RPH 60337, AC 7223 conditions. AC 7698 Newport Beach, CA Eective 6/19/2025. Coalinga, CA Morales, Daisy, TCH 175896, Purchased and/or Warehoused AC 7954 Dangerous Drugs From North Hollywood, CA Alcohol. Unlicensed Wholesalers Against Respondents; Held or Oered Conviction, Wet Reckless; for Sale Adulterated Drugs; Sold or Delivered Adulterated Drugs; Security Act; Inappropriate Exercise of Education, Training or Experience; Unprofessional Conduct. Naghi, Pantea, RPH 52061, Pacheco, Adolfo Najera, Action: The g license is revoked, AC 7552 TCH 190165, AC 7901 Beverly Hills, CA Oxnard, CA Unprofessional Conduct, Conviction, Public Nuisance failed to comply with statutes & Carry a Concealed Firearm; governing controlled substance Act Involving Moral Turpitude; prescriptions by failing to Violation of Statute Regulating reduce prescriptions to writing Controlled Substances and Patel, Shital J., RPH 50125, and by failing to sign and date Dangerous Drugs. AC 7538 prescriptions; dispensed dozens La Palma, CA of prescriptions for controlled substances, and in some cases Purchased and/or Warehoused prescription rells, to patients Dangerous Drugs From Patel, Kinjal Ghanshyam, in states in which Respondents Unlicensed Wholesalers Against RPH 61294, AC 7539 were not licensed or registered; Respondents; Held or Oered Irvine, CA Failure to Ensure Compliance for Sale Adulterated Drugs; Sold -with Pharmacy Law. or Delivered Adulterated Drugs; Purchased and/or Warehoused Dangerous Drugs From Security Act; Inappropriate Unlicensed Wholesalers Against Exercise of Education, Training Respondents; Held or Oered thirty-ve (35) months subject to or Experience; Unprofessional for Sale Adulterated Drugs; Sold Conduct. or Delivered Adulterated Drugs;

See Disciplinary Actions, Page 33

Inventories; Failure to have Elk Grove, CA Reconciliation Reports; Failure Continued from page 32 to have Records Regarding Unprofessional Conduct, Dangerous Drugs and Dangerous Conviction of a Crime; Multiple Devices; Failure to have Self- convictions involving alcohol. Assessments; Collection of Drugs Without DEA Registration; Failure to Properly Maintain Pharmacy; Failure to Use Compliant Labels; (Failure to have Policies Patel, Shital J., RPH 50125, and Procedures Regarding AC 7618 Quality Assurance; Failure to La Palma, CA have Policies and Procedures Santibanez, Gabriela, TCH 11013, Regarding Theft and Impairment; Purchased and/or Warehoused AC 7840 Failure to have Policies and Dangerous Drugs From Procedures Regarding Temporary Unlicensed Wholesalers Against Absence of Pharmacist; Failure Respondents; Held or Oered Conviction for Conspiracy to to have Pharmacy Technician for Sale Adulterated Drugs; Sold Commit HealthCare Fraud; Job Description; Improper or Delivered Adulterated Drugs; Moral Turpitude; Unprofessional Pharmacist to Pharmacy Conduct. Technician Ratio; Failure to Security Act; Inappropriate have Policies and Procedures Exercise of Education, Training Regarding Assisting Patients or Experience; Unprofessional with Limited or No English Conduct. Prociency; Failure to Correctly Schaefer, Mark Allen, RPH 32265, Display the "Point to Your AC 7847 Language" Sign; Failure to Correctly Display License. Phan, Danggiao The, RPH 61955, AC 7733 Upland, CA Truong, Stephanie, RPH 81161, Reyes, Franklin Eliseo, AC 7638 Unprofessional Conduct; Misuse TCH 117755, AC 7944 Arleta, CA of Education; Erroneous or Los Angeles, CA Uncertain Prescriptions. Unauthorized Possession of Conviction, Battery; Act Involving Licensing Examination Content; Moral Turpitude. Violation of Examination - Security; Unprofessional Conduct. Phan, Timothy, RPH 80237, AC 7872 Anaheim, CA Rivera, Nizhoni Aloni, TCH 81410, AC 7779 to have Controlled Substances

See Disciplinary Actions, Page 34

Conduct.

Continued from page 33

Van Liere, Taylor N., TCH 190241, AC 7828 the decision. AHCS Specialty Care, PHY 55932, Westlake Village, CA AC 7618 Cause for discipline: Moral Zavala, Anthony, TCH 148012, Garden Grove, CA Turpitude, Fraud, Dishonesty, AC 7477 Deceit, or Corruption; Dangerous Palmdale, CA Self-Administration of Controlled Drugs; Held or Oered for Sale Substances; Violation of Adulterated Drugs; Sold or Controlled Substances Law; Unlawful Transport, Furnishing, Violation of Any Provision of and Sale of Controlled the Pharmacy Laws; Conduct Substances; Unlawful Possession Warranting License Denial; of a Controlled Substance; Conduct. Criminal Conviction; Dangerous Unlawful Possession of a Use of a Controlled Substance. Controlled Substance; Violations of the Pharmacy Law. AHCS Specialty Care, PHY 58059, AC 7618 Garden Grove, CA Eective 5/14/2025. Facility Licenses Vela, Renee, TCH 165087, Drugs; Held or Oered for Sale AC 7781 AHCS Specialty Care, PHY Adulterated Drugs; Sold or Hacienda Heights, CA Applicant, SI 7210 Use of Alcoholic Beverages and/ or a Dangerous Drug; Knowingly Conduct. Made or Signed Any Certicate Drugs; Held or Oered for Sale or Other Document That Falsely Adulterated Drugs; Sold or Represents the Existence or Nonexistence of a State of Facts. AHCS Specialty Care, PHY 58059, Conduct. AC 7618 The application is denied. Garden Grove, CA

Drugs; Held or Oered for Sale AHCS Specialty Care, PHY 55932, Adulterated Drugs; Sold or AC 7538 Yam, Jenny Yan, RPH 59408, Garden Grove, CA -AC 7692 San Gabriel, CA Conduct. Drugs; Held or Oered for Sale Misbranded Drugs; Selling Adulterated Drugs; Sold or Expired Drugs; Failure to Maintain Records and Current Inventory. See Disciplinary Actions, Page 35

Components Utilized during or Uncertain Prescriptions As Compounding. Against Respondent Cabrera; Continued from page 34 Records and Inventory: Records AlixaRx, PHY 59130, AC 7798 Relating to Dangerous Drugs and Devices; Inventory Reconciliation Cause for discipline: Dispensing Report of Controlled Substances; Apex Community Pharmacy, Incorrect Tubing for a Dangerous Unprofessional Conduct: Moral PHY 57627, AC 7853 Device; Failure to Document Lemon Grove, CA an Error/Quality Assurance; or Corruption; Furnishing Failure to Properly Document Dangerous Drugs without a Unprofessional Conduct: Acts Components Utilized during Prescription; Failure to Take Compounding. Ensure Compliance with Pharmacy Law; Dispensing Corruption; Maintenance of Dangerous Drugs Out of State Records/Operational Standards without a License; Erroneous or and Security; CURES Project Uncertain Prescriptions; Records for Electronic Monitoring of of Acquisition and Disposition AlixaRx, LSC 101861, AC 7798 Prescription Drugs; Inventory of Dangerous Drugs and Reconciliation Report of Devices; Furnishing Dangerous Cause for discipline: Dispensing Controlled Substances; Drugs without a Prescription; Incorrect Tubing for a Dangerous Biennial Inventory; Procedures Unprofessional Conduct: Moral Device; Failure to Document Addressing Chemical, Mental, an Error/Quality Assurance; or Physical Impairment; Failure or Corruption; Unprofessional Failure to Properly Document to Maintain Patient Centered Conduct: Moral Turpitude, Components Utilized during Labeling for Prescription Drug Dishonesty, Fraud, or Corruption. Compounding. Containers; Failure to Maintain Policies and Procedures Regarding Operation of Pharmacy During Absence of Pharmacist; Failure to Maintain Crescent Drugs, Inc., PHY 50359, Quality Assurance Programs; AC 7552 AlixaRx, PHY 51693, AC 7798 Failure to Maintain Pharmacy Culver City, CA Technician Job Descriptions or Cause for discipline: Dispensing Policies; Failure to Complete Unprofessional Conduct, failed Incorrect Tubing for a Dangerous Self-Assessment of Pharmacy to reduce prescriptions to Device; Failure to Document Compliance with Federal and writing and failed to sign and an Error/Quality Assurance; State Pharmacy Law; Failure to date prescriptions; dispensed Failure to Properly Document Display License; Duty to Consult. prescriptions for controlled Components Utilized during substances, and in some cases Compounding. prescription rells, to patients in states in which Respondents were not licensed or registered. -California Pharmacy and AlixaRx, LSC 99953, AC 7798 Compounding Center, PHY 57141, AC 7187 thirty-ve (35) months subject to Cause for discipline: Dispensing Newport Beach, CA Incorrect Tubing for a Dangerous Device; Failure to Document or Uncertain Prescriptions As an Error/Quality Assurance; Against Respondent Pharmacy Failure to Properly Document and Respondent Hall; Erroneous See Disciplinary Actions, Page 36

HRx Pharmacy LLC, NRP 1973, AC 7838 Continued from page 35 Salt Lake City, UT CVS Pharmacy #09509, PHY Cause for discipline: Out of 49596, AC 7585 State Discipline. Concord, CA to Maintain Appropriate Action: The license is placed Excel Specialty Pharmacy LLC, Temperature in Pharmacy; on probation for thirty months PHY 57135, AC 7527 Failure to Maintain Pharmacy subject to the terms and Clovis, CA Cleanliness. Cause for discipline: Holding Eective 4/23/2025 Expired and Adulterated Medications; Prohibited Lihue Pharmacy Inc., Acts, Dispensing of Expired NSC 101126, AC 7843 Medications; Failure to Complete Lihue, HI Entrega Pharmacy, PHY 58149, a Controlled Substance AC 7872 Inventory; Failure to Conduct Assignment of Unsupported Lancaster, CA Required Quarterly Schedule II Controlled Substance to have Controlled Substances Inventory Reconciliation; Inventories; Failure to have Failure to Transmit a Controlled Reconciliation Reports; Failure Substance Prescription to CURES; to have Records Regarding Unauthorized Prescription; Excessive Furnishing of Orally Transmitted Prescription; Dangerous Drugs and Dangerous a Controlled Substance; Devices; Failure to have Self- Assessments; Collection of Drugs Maintenance of Records. Gross Negligence; Assignment Without DEA Registration; Failure of Unsupported Extended to Properly Maintain Pharmacy; Beyond Use Dates; Failure to Failure to Use Compliant have a Compliant Compounding Labels; Failure to have Policies Environment; Misbranded Drugs; and Procedures Regarding decision. Failure to Follow Policies and Quality Assurance; Failure to Eective 4/7/2025. have Policies and Procedures Garden Grove Community Regarding Theft and Impairment; Pharmacy, PHY 51109, AC 7223 Failure to have Policies and Garden Grove, CA Procedures Regarding Temporary Absence of Pharmacist; Failure to have Pharmacy Technician Drugs From Unlicensed Job Description; Improper Wholesalers; Held or Oered for Pharmacist to Pharmacy Sale Adulterated Drugs; Sold or Technician Ratio; Failure to -have Policies and Procedures Lihue Pharmacy Inc., NRP 2040, Regarding Assisting Patients AC 7843 with Limited or No English Conduct. Lihue, HI Prociency; Failure to Correctly Display the "Point to Your Assignment of Unsupported Language" Sign; Failure to Correctly Display License.

See Disciplinary Actions, Page 37

This newsletter is published by the California State Board of Pharmacy Department of Consumer Aairs 2720 Gateway Oaks Drive, Suite 100 Continued from page 36 Sacramento, CA 95833 Mission Plaza Pharmacy 3, (916) 518-3100 PHY Applicant, Statement of Fax: (916) 574-8618 Issues Case SI 7211 www.pharmacy.ca.gov Anaheim, CA BOARD MEMBERS Purchased and/or Orally Transmitted Prescription; Warehoused Dangerous Seung Oh, Pharm.D. Drugs From Unlicensed President Wholesalers; Held or Oered Gross Negligence; Assignment for Sale Adulterated Drugs; Jessica Crowley, Pharm.D. of Unsupported Extended Sold or Delivered Adulterated Vice President Beyond Use Dates; Failure to Drugs; Violations of Drug have a Compliant Compounding Supply Chain Security Act; Trevor Chandler, Public Member Environment; Misbranded Treasurer Drugs; Failure to Follow Policies The application is denied. and Procedures; Failure to Initial Renee Armendariz Barker, Pharm.D. Je Hughes, Public Member Smith Pharmacy, PHY 41098, Kartikeya "KK" Jha, Licensee Member AC 7692 Claudia L. Mercado, Public Member Los Angeles, CA Jason Newell, Public Member Ricardo Sanchez, Public Member Misbranded Drugs; Selling Satinder Sandhu, Pharm.D. Expired Drugs; Failure to Maria D. Serpa, Pharm.D. Maintain Records and Current Nicole Thibeau, Pharm.D. Inventory. Action: The license is STAFF Mission Plaza Pharmacy, revoked, the revocation PHY 51550, AC 7539 stayed, the license is placed Anne Sodergren on probation for three years Executive Ocer subject to the terms and conditions in the decision. Julia Ansel Drugs From Unlicensed Deputy Executive Ocer Wholesalers; Held or Oered for Sale Adulterated Drugs; Sold or Sara Jurrens Editor Victor Perez Conduct. Layout/Design

California State